Innovative Cell Therapy, Omisirge, Receives FDA Approval to Reduce Infection Risk in Blood Cancer Treatments
The FDA has approved Omisirge (omidubicel-onlv), a modified allogeneic cord blood-based cell therapy designed to speed up the recovery of neutrophils and reduce infection risk. Omisirge is intended for use in adults and pediatric patients aged 12 and older with blood cancers who are undergoing umbilical cord blood transplantation after a myeloablative conditioning regimen. Blood […]
Be The Match: How you can donate plasma, stem cells to help cancer patients
Good Day Philadelphia shares Fox 29’s sports anchor, Breland Moore’s story of how she donated her plasma and bone marrow stem cells to help a man with cancer. This was all done through Be The Match – an incredible organization that manages the most diverse marrow registry in the world to help patients with life-threatening […]